ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Schizotypal Personality Disorder

  • Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer
  • Exceptional Experiences (EE), Salience & Dopaminergic Neurotransmission
  • Schizotypal Personality Disorder Risperidone
  • CRT-Guanfacine for SPD
  • A D1 Agonist For Working Memory
  • Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations
  • Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder
  • Pharmacology of Cognition in Schizotypal Personality Disorder
  • Pergolide for Cognitive Symptoms in Schizotypal Personality Disorder
  • Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms
  • Aripiprazole Treatment of the Prodrome
  • Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group